AGP Executive Report
Last update: 3 hours agoHepatitis B Breakthrough: Singapore-led studies report an experimental hepatitis B drug (bepirovirsen) may deliver a “functional cure” for about 1 in 5 patients, with longer-term durability still being studied. Public Health & Food Safety: NEA says rat activity remains a concern, with penalties in 230+ F&B cases in 2025; Little India sightings are down ~40% and video analytics are being explored. Hearing Health: A new push highlights hearing loss as a whole-body risk linked to dementia and cardiovascular disease, alongside emerging treatments. Mosquito Control Watch: Google/Verily seeks EPA permission to release up to 64 million Wolbachia-carrying “good” male mosquitoes in Florida and California to curb dengue and other diseases; Singapore trials are cited as earlier proof points. Local Healthcare Leadership: Dr Koh Poh Koon is returning to clinical work as a surgeon after stepping down from MOH roles. Nutrition & Sugar: Thailand moves to cut sugar in iced drinks after high intake concerns—another reminder for Singapore’s beverage labeling push. Workplace Wellness: Singapore is studying ways to better support at-risk workers before job losses, with Desmond Choo highlighting burnout and transition needs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.